N aturally occurring regulatory T (Treg) cells play a central role in the maintenance of immune homeostasis and selftolerance in the T lymphocyte compartment (1) . The balance between effector T cells and Treg cells is important for the suppression of inflammatory responses against self-Ags. Thus, the homeostasis of Treg cells in vivo is crucial to prevent the development of spontaneous inflammatory responses.
Treg cells express activation markers, such as CD25, CD5, and cytotoxic CTLA-4, which are otherwise induced in naive T cells only by strong TCR signaling. However, Treg cells exhibit an anergic phenotype (2) (3) (4) . The suppressive and anergic characteristics of Treg cells are mainly regulated by Foxp3, a lineagespecific transcription factor (5-7). Furthermore, sustained Foxp3 expression is necessary for the maintenance of the Treg cell phenotype and for suppressor function (8) . In addition, these activation markers also function as suppressive molecules to compete with effector T cells, for example, by costimulation blockade or by cytokine consumption, and so on (9) . Of particular note, Treg cells express a high level of IL-2Ra (CD25); mice lacking the Il-2 or Il-2ra gene have a decreased percentage of Foxp3 + CD4 T cells and manifest an aggressive lymphoproliferative autoimmune disease (2, 10, 11) , indicating the importance of CD25 in Treg maintenance. In addition, CD25 is essential for maintaining the homeostasis of Treg cells in vivo via regulation of genes involved in cell metabolism; the principal source of IL-2 is other T cells, such as self-reactive T cells (11) (12) (13) (14) . Foxp3 directly regulates CD25 expression, which, although attenuated, is still highly expressed in Foxp3-deficient Treg cells (15) . These observations indicate that additional transcription factors are involved in CD25 regulation in Treg cells. However, regulatory mechanisms other than Foxp3 controlling CD25 expression in Treg cells are less well understood.
Dec1 (also known as Stra13 or Sharp2) is a basic helix-loophelix (bHLH) transcription factor that has been reported to play a role in the circadian system (16, 17) . Its expression is substantially elevated in response to different stimuli such as light pulses, growth factors, or hypoxia (16, 18, 19) . Dec1 is also reported to be involved in TGF-b signaling in the circadian system and in cancer cells (20) (21) (22) . Curiously, aged Dec1 2/2 mice develop autoimmune disease, even though their naive CD4 T cells are normal or hyporesponsive to TCR stimulation in terms of proliferation and secretion of cytokines, such as IFN-g (23) . Therefore, we considered that a dysregulated immunosuppressive function might account for lymphoproliferative disease in older Dec1 2/2 mice.
In this paper, we report that Dec1 is highly expressed in Treg cells and that Dec1 deficiency causes a decrease in Treg cell number in aged mice and that a significant proportion of aged Dec1-deficient mice exhibit the development of lymphoproliferative autoimmune disease. In addition, we show that Dec1 is required for the longterm maintenance of Treg cells after adoptive transfer to suppress effector T cell-mediated inflammation. Dec1 appears to positively regulate CD25 expression in association with Runx1, and these data link Dec1 and Runx1 into a common pathway to regulate Treg cells.
Materials and Methods

Mice
Targeting of the Dec1 locus was performed by standard techniques. The BssHII-BssHII genomic fragment of Dec1 as previously described (23) , which contains the promoter and coding region including the ATG in exon1, was replaced with a Neo cassette. The resulting chimeric mice were backcrossed to C57BL/6 more than six to eight times. Dec1 transgenic (Tg) mice were generated using the Lck proximal promoter transgene cassette vector as described previously (24) . We generated two independent Dec1 Tg mouse lines. CD25 Tg mouse was generated using the cassette vector in which CD25 cDNA is driven by the CD4 enhancer and promoter that was provided by Dr. I. Taniuchi (The Institute of Physical and Chemical Research [Japan] Research Center for Allergy and Immunology, Yokohama, Japan). C57BL/6 (B6, ly5.2) mice were obtained from CREA Japan (Tokyo, Japan), and B6 SJL Ptprca Pep3bBoyJ (B6, Ly5.1) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All mice were kept in accordance with the laboratory animal science guidelines of Hiroshima University (Hiroshima, Japan).
Flow cytometry and Abs
Single-cell suspensions from thymus, spleen, and mesenteric lymph node were stained with mAbs and second reagents. FITC-, PE-, allophycocyanin-, allophycocyanin-Cy7, biotin-labeled, and purified mAbs were purchased from BD Pharmingen (San Diego, CA) (CD4, CD8a, CD3ε, CD44, CD62L, CD25, CD45R/B220, Mac-1, Gr-1, Ter119, NK1.1, CD45.2, and CD45.1) or from eBioscience (San Diego, CA) (CD4, CD3ε, CD127, CD25, and Foxp3). Mouse Treg cell staining kit (eBioscience) was used for Foxp3 staining. Biotinylated Abs were revealed with streptavidin-FITC, -PE, -PerCP-Cy5.5, -allophycocyanin, or -allophycocyanin-Cy7. Clone 2.4G2 anti-CD32:CD16 was used to block FcRs. FACS analysis was performed on a FACSCalibur (BD Biosciences, San Jose, CA) or FACSVantageSE (BD Biosciences), and data were analyzed with FlowJo (Tree Star, Ashland, OR) software. For cell sorting, all cells were stained with biotinylated Abs, bound to streptavidin magnetic beads, and depleted by MACS separation column (Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were subsequently sorted with a FACSVantageSE (BD Biosciences). Dead cells were removed from analysis and sorting by staining with propidium iodide. Reanalysis of the sorted cells indicated a purity .98% for each cell population. Rabbit polyclonal Ab against DEC1 was prepared as follows. GST-DEC1 fusion protein was prepared using the recombinant prokaryotic expression vector pGEX-4T-2 (GE Healthcare Biosciences, Piscataway, NJ) including the sequence encoding the amino acids of the mouse Dec1 protein. The fusion protein was used to immunize rabbit for producing the antiserum, and the polyclonal Ab against DEC1 was purified from the obtained serum by affinity column.
Preparations of CD4 +
CD25
+ cell populations
Splenocytes were harvested from 8-to 12-wk-old Dec1
, or Dec1 Tg mice, and the red cell fraction was eliminated by lysis. Splenocytes were stained with biotin-labeled anti-CD8, -TCRgd, -CD19, -CD11b, -Gr-1, -Nk1.1, allophycocyanin-CD4, and PE-CD25 Abs and bound to streptavidin-magnetic beads. Then, cells were depleted by MACS separation column (Miltenyi Biotec) and were sorted CD4 + CD25
+ cells on a FACSVantageSE. These cells were used for in vitro and in vivo suppression assays.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay of thymocyte with antiacetylated H3 (Upstate Biotechnology, Lake Placid, NY), anti-Runx1 (Active Motif, Carlsbad, CA), purified anti-Dec1 and control (Santa Cruz Biotechnology, Santa Cruz, CA) Abs were performed as described previously (24) . In brief, isolated total thymocyte or sorted double-positive (DP) cells were fixed with 1% formaldehyde at room temperature and sonicated. Soluble chromatin was immunoprecipitated with Abs overnight. PCR was performed with SYBR Premix Ex Taq for real-time PCR (TaKaRa, Shiga, Japan). The sequences of the PCR primers are available on request. For ChIP assay using Treg cells, sorted CD4 + CD25
+ Treg cells were fixed and sonicated. Then, we used Low Cell# ChIP kit (Diagenode, Denville, NJ).
Immunoprecipitation and Western blotting
Expression vectors for Flag-tagged Runx1 and hemagglutinin (HA)-tagged Dec1, which contain their entire coding region sequences, respectively, were prepared using pcDNA3.1 vector. The Runx1 deletion constructs (d402 and d362) were provided by Dr. S. Sakaguchi (25) . Deletion constructs of Flag-tagged Runx1 (d290 and d178) and HA-tagged Dec1 were made by PCR. Flag-tagged Runx1 and HA-tagged Dec1 constructs were cotransfected into COS7 cells using FugeneHD (Roche, Basel, Switzerland), according to the manufacturer's instructions. The cells were harvested in ice-cold PBS, and the cell pellet was resuspended in ice-cold 0.5% Triton lysis buffer, followed by centrifugation 4˚C for 30 ) cells were prepared from mouse lymph nodes using Abs and MACS columns as described in the section of the preparation of CD4 + CD25
+ cell populations. The cells were fixed with 4% paraformaldehyde and permeabilized with 0.03% Triton X-100 for 10 min at room temperature. After washing with PBS, the cells were stained by anti-Dec1 Ab for 1 h at room temperature, washed and stained by Alexa Fluor 555-conjugated anti-rabbit secondary Ab. Subsequently, the cells were stained by anti-Runx1 Ab (Active Motif), which was direct-labeled with Alexa Fluor 488 using Zenon rabbit IgG labeling kit according to the manufacturer's instructions (Molecular Probes, Eugene, OR). After washing with PBS, Hoechist 33342 was used for DNA staining. Controls were performed by staining cells only with secondary Ab.
RT-PCR (quantitative real-time RT-PCR)
Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA) and was reverse transcribed to cDNA using SuperScriptIII (Invitrogen). The cDNA was used for quantitative real-time RT-PCR or semiquantitative RT-PCR with SYBR Premix Ex Taq (TaKaRa) or Ex Taq polymerase (TaKaRa), respectively. The PCR primers sequences are as follows: mouse Dec1, 59-GGGAATAAAACGGAGCGAAGAC-39 (forward) and 59-CACAAGTCT-GGAAACCTGAGCA-39 (reverse); mouse CD25, 59-CCACATTCAAAG-CCCTCTCCTA-39 (forward) and 59-GTTTTCCCACACTTCATCTTGC-39 (reverse); mouse HPRT, 59-GCTGGTGAAAAGGACCTCTCG-39 (forward) and 59-CCACAGGACTAGAACACCTGC-39 (reverse); and mouse b-actin, 59-TTCAACACCCCAGCCATGTA-39 (forward) and 59-CTCAGGAGGA-GCAATGATCT-39 (reverse).
Statistical analysis
The p values were calculated with the two-tailed Student t test for two group comparison as applicable with Microsoft Excel software. The statistical significance level was 0.05. CD4 or CD8 naive T cells on the C57BL/6 genetic background (Supplemental Fig. 1 ). In addition, we observed less marked differentiation from naive Dec1 2/2 CD4 T cells to IFN-g-secreting T cells following TCR stimulation in vitro (data not shown). We failed to find any obvious hyper-responsiveness to TCR stimulation in naive Dec1-ablated T cells. Unlike in the previous report (23) , on the C57BL/6 genetic background, we did not identify any Dec1 2/2 mouse exhibiting the lymphoproliferative phenotype within a 10-mo period. However, at .1.2 y of age, some of these mice manifested lymphoproliferative disease (4 females of 20 mice at .1 y old showed splenomegaly and lymphadenopathy; Fig. 1D , Supplemental Fig. 2) , with CD4 T cells highly expressing the activation markers CD44 and CD69 together with lower expression of CD62L (Supplemental Fig. 3 ). Histological analysis showed massive infiltration of polyclonal lymphocytes into systemic organs and dissolution of the normal architecture, such as red pulp and white pulp in the spleen, or loss of germinal center formation in lymph nodes (Supplemental Fig. 2 ). We found a marked reduction in the percentage of CD25 + or Foxp3 + Treg cells among the CD4 T cells in mice with lymphoproliferative disease (Fig. 1E) . It is well known that mutations in Fas and Fas ligand also result in autoimmune disease because of defects in the elimination of activated T and B cells (26) . The accumulation of DN T cells is characteristic of those mutant mice (27) . However, we observed no such accumulation of DN T cells in any of the aged Dec1 2/2 mice (Supplemental Fig. 4 ). mice without lymphoproliferative disease, whereas the expression of these markers in young adult Dec1 2/2 mice was normal (Supplemental Fig. 6 ). On the basis of these observations, we propose that a deficiency in Dec1 caused a reduction in the numbers of Treg cells and subsequent dysregulation of T cell activation in aged mice while their status of proliferation and survival was not affected. Furthermore, we suggest that these defects eventually increase the susceptibility to systemic lymphoproliferative disease.
Results
Dec1
Dec1 plays a crucial role in maintaining Treg cells, which are required for the suppression of effector T cell-mediated autoimmunity that stable Foxp3 expression is regulated by DNA demethylation at the evolutionarily conserved region within the Foxp3 locus (28) . However, the status of this locus in Dec1 2/2 Treg cells was found to be highly demethylated, similar to control Treg cells (Supplemental Fig. 10 ).
Dec1 is involved in induced Treg cell development by supporting their survival or proliferation
Next, we examined the involvement of the Dec1 gene in the induction of Foxp3 expression in CD4 + CD25 2 non-Treg cells (induced Treg; iTreg) by TCR stimulation in the presence of TGF-b in vitro. There was a significant reduction in the development of iTreg cells from Dec1 2/2 non-Treg cells (Fig. 3A) . TGF-b signaling is thought to be required not only for iTreg but also for the differentiation of IL-17-producing T (Th17) cells (29, 30 Fig. 11 ), indicating that reduced iTreg might not be simply caused by defects of TGF-b signaling in Dec1 2/2 T cells.
Interestingly, exogenous IL-2 completely overcame the impairment in iTreg cell development from Dec1 2/2 non-Treg cells, suggesting that Dec1 is involved in the survival or expansion of iTreg cells but not in their commitment and that excess exogenous IL-2 overcomes these defects even in the absence of the Dec1 gene (Fig. 3B ).
Enforced expression of Dec1 increases the number of Treg cells
To investigate whether enhanced expression of Dec1 reciprocally influenced Treg cells, we generated Tg mice expressing Dec1 in a T cell lineage-specific manner, with the transgene under the control of the lck-proximal promoter. In contrast to Dec1 2/2 mice, we observed an increased percentage of Foxp3 + cell among CD4 T cells in Dec1 Tg mice compared with wild-type (WT) mice (Fig. 4A) 
Dec1 upregulates CD25 expression
We next investigated target genes of Dec1 in T cells by detailed analysis of Dec1 Tg mice. We verified the high expression of Dec1 in Dec1 Tg thymocytes (Supplemental Fig. 13 ). In our analysis of thymocyte development, we noticed an accumulation of DN cells and a decrease in CD4 or CD8SP cells. Among lineage neg cells, a marked increase in DN3 cells and reduction of DN4 cells in Dec1 Tg mice was observed (Supplemental Fig. 14) . These results suggest impairments in b selection and positive selection during thymocyte development. We confirmed defects in b selection and positive selection of Dec1 Tg thymocyte using fetal thymic organ cultures and reaggregation thymic organ cultures (data not shown). During our investigations of Dec1 Tg thymocyte development, we 
CD62L
high cells from 8-to 12-wkold Dec1 +/+ or Dec1 2/2 mice were cultured on the plate-bound anti-CD3 plus anti-CD28 Abs (5 mg/ml) in the presence of TGF-b1 (2 ng/ml The Journal of Immunologyfound abnormal expression of CD25 in the DP cells of these mice, despite little expression in WT DP cells (Fig. 5A, 5B) . Although there were marked increases of CD25 high cells within the CD4SP subpopulation, we found normal Foxp3 expression in Dec1 Tg CD4SP cells (Fig. 5C ). These results indicate that Dec1 could induce CD25 expression but not Foxp3 directly during thymocyte development. CD25/IL-2Ra is strictly regulated during T cell development and is necessary for the maintenance of Treg cells in the periphery. Previous studies have collectively identified positive regulatory regions (PRRs) in the Il-2ra locus, to which various transcriptional factors can bind (31) (Fig. 5D, upper panel) . Therefore, we investigated the acetylation status of histone H3 at these PRRs (PRRI-V) in Dec1 Tg DP cells by ChIP assays. The degree of H3 acetylation was higher at PRRI, II, III, and V and was similar at PRRIV in the Il-2ra locus in Dec1 Tg DP cells, compared with control DP cells (Fig. 5D, lower panel) . These results suggest that one of the target genes of Dec1 is Cd25/Il-2ra.
We next investigated whether Dec1 was required for the induction of CD25 expression in naive T cells on TCR signaling. There were no significant differences in CD25 expression by either CD4 or CD8 T cells from Dec1 (Fig. 6B) . On the basis of these observations, we suggest that CD25 is involved in the impaired maintenance of Dec1 2/2 Treg cells after adoptive transfer.
Dec1 binds to the Il-2ra locus together with Runx1 in Treg cells
We next sought to determine whether endogenous Dec1 actually bound to the Il2ra gene locus in Treg cells. Purified CD4 + CD25 + Treg cells from Dec1 +/+ or Dec1 2/2 mice were tested in ChIP assays using Ab against the Dec1 protein. We detected Dec1 binding at PRRV, PRRIV, and intron1 (5) in Dec1 +/+ Treg cells but not Dec1 2/2 cells (Fig. 7A, upper panel) . However, we could not find an E-box sequence, reported as a Dec1 binding site (32) in these regions. Thus, we hypothesized that Dec1 is recruited to the Il-2ra locus together with other transcription factors that bind to these sites. It has recently been reported that Runx1 bound to Il2ra loci and collaborated with Foxp3 (25) . We did find the Runx1-DNA binding consensus sequence in PRRV and PRRIV; especially, PRRIV had been previously reported as a Runx1 binding site. In addition, we found a Runx1-binding sequence close to the amplicon of intron1 (5) . Runx proteins bind to the regulatory elements of target genes together with other transcription factors and can function as activators or repressors (33) . Accordingly, we explored the binding capacity of Dec1 for Runx1. In IP experiments using lysates of COS7 cells cotransfected with genes encoding HA-tagged Dec1 and Flag-tagged Runx1 proteins, we found that Dec1 bound to Runx1 in vitro (Fig. 7B) . Furthermore, IP experiments using deletion mutants showed that Runx1 lacking the C-region (aa 363-402) failed to bind to Dec1 (Fig. 7C) . Simi- + lar experiments using deletion mutants of Dec1 indicated that the Runx1-interacting domain of Dec1 was located in the region between 125 and 188 aa, including the ORANGE domain found in Hairy/E(SPL) family of bHLH proteins (34) (Fig. 7D) . We observed the colocalization of these factors in the nucleus by immunofluorescent staining in vitro (Supplemental Fig. 15 ). Furthermore, endogenous Dec1 and Runx1 were partly colocalized in the nonheterochromatin area in the nucleus of CD4 + CD25 + Treg cells, but not in non-Treg cells, in which little expression of Dec1 was found (Fig. 7E) . These results caused us to investigate how Runx1 bound to the Il-2ra locus in Dec1 2/2 Treg cells. Curiously, Runx1 was found to bind to the same sites as Dec1 in the Il-2ra locus in Dec1 +/+ Treg cells, and accordingly, its binding was drastically reduced in Dec1 2/2 Treg cells (Fig. 7A, lower panel). These results suggest that Dec1 binds to the Il-2ra locus upon interacting with Runx1. We propose that Dec1 binding is required for Runx1 DNA binding to regulatory elements present in the Il-2ra locus in Treg cells and that this interaction is specific for Treg cells.
Discussion
Because it was observed that the Dec1 gene is downregulated in DP cells and induced again in CD4 or CD8SP cells (Fig. 1B) , we analyzed its role in positive and negative selection of DP thymocytes by intercrossing HY-TCR Tg or AND-TCR Tg mice. Interestingly, Dec1 Tg mice exhibited markedly impaired positive and negative selection of DP cells, even though no obvious defects in thymocyte selection were observed in HY-TCR Tg:Dec1 Treg cells express normal levels of CD25 and CTLA-4 and mediate normal suppressive function at early time points in vivo, Treg cells failed to suppress at later time points. This was associated with a reduced number of Treg cells remaining after 8 wk in adoptive transfer models. These observations suggest that Dec1 is involved in the long-term maintenance of Treg cells after their adoptive transfer. Dec1 deficiency causes a reduction in the numbers of Treg cells in aged but not young mice, accompanied by increased activation of effector T cells. At younger age, many non-Treg as well as Treg cells are produced in the thymus and exported to the periphery. However, the supply of Treg cells is gradually reduced in mice as they age. Therefore, we propose that Treg cell retention is more important for maintaining immune homeostasis in aged than young mice because of the reduced output of new Treg cells from aged thymus and, accordingly, that the Dec1 gene is mainly required for the suppression of spontaneous inflammation by maintaining Treg cells. However, we note that the reduction of Treg cells in aged Dec1 2/2 mice was not severe and the proliferation status and bcl-2 expression in aged Dec1 2/2 Treg cells were comparable to that with control Treg cells (Supplemental Fig. 5 ). It has been reported that the number of Treg cells are immediately and severely decreased after thymectomy, and the remaining Treg cells exhibits increased proliferation (38). Therefore, it remains unclear whether Dec1 is required for the maintenance of Treg cells in periphery, their production in thymus, and/or their emigration from thymus in aged mice. We also observed an increasing CD25 + Foxp3 2 CD4
SP cells in Dec1 Tg thymus (Fig. 5C ). It is conceivable that this compartment contains Treg precursors. This raises another possibility that Dec1 may be involved in the production of thymic Treg precursor cells and that the reduced production of precursor cells may give rise to a decrease in peripheral Treg cells in aged Dec1 2/2 mice. In addition, many aged Dec1 2/2 mice showed less Treg cells and more activated effector T cells. However, few mice suffered from lymphoproliferative disease in .1-y-old mice, indicating that additional factors, such as infection, are necessary for the incidence of autoimmune disease. We note that this is similar to human autoimmune diseases, some of which are induced or exacerbated by infection. IL-2 signaling has a central role in the homeostasis of Treg cells in the mouse model (3). CD25 also plays a crucial role in several human autoimmune diseases in which lymphadenopathy and hepatosplenomegaly is observed, because these are associated with CD25 mutations (39). IL-2 signaling in Treg cells is required for their maintenance in vivo, although CD25-deficient Treg cells retain normal suppressive function in vitro (11) . Although Dec1 2/2 naive T cell expressed comparable levels of CD25 following TCR stimulation (data not shown), we observed that IL-2R signaling also upregulates Foxp3 expression (40). STAT5 actually binds to Foxp3-CNS2, and a constitutively active STAT5 can expand Treg cells (41, 42). We also found that the percentages of Ly5.1 cells within the CD25 2 population after transfer of Dec1 2/2 Treg cells were comparable to controls (Supplemental Fig. 8 ). This indirectly suggests that at least the majority of Ly5.2 + Dec1 2/2 Treg cells did not convert into effector T cells. It is possible that some elements representing less stable Treg cells, such as iTreg cells, could convert into effector T cells and that Dec1 also prevents this conversion via maintaining CD25 expression. This idea is based on the report that CD25 expression levels appear to be important for resistance to conversion in adoptive transfer models (43). Dec1 is highly expressed in Treg cells, and its expression is not altered in Foxp3-deficient Treg cells. Thus, CD25 expression could be compensated by factors other than Foxp3 in those cells because Foxp3-deficient cells still express CD25 (15) . Therefore, we suggest that Dec1 is involved in CD25 expression in Treg cells and is required for Treg survival or expansion. In addition, it is possible that Dec1 regulates other target genes than CD25, independently of Foxp3. Dec1 is reported to bind E47 (44); we also saw binding of Dec1 and E47 and their colocalization in vitro (our unpublished data). The E2a gene, which encodes E12 and E47, has a crucial role not only in B cell development, but also in T cell development (45) . E47 regulates cellular expansion, developmental progression, and cell death through control of the expression of genes such as Cdk6, CD25, Gadd45a/b, Socs1/3, IL-7R, and so on (46). Thus we believe that there is a functional overlap between E47 and Dec1 in T cell development, because, in addition to upregulation of CD25, IL-7Ra was remarkably downregulated in Dec1 Tg thymocyte (our unpublished data). Further study is required to understand Dec1 and E2A interactions and their implications for T cell function.
A previous report showed that Runx1 interacts with Foxp3 and represses IL-2 expression or upregulates CD25 when introduced into primary CD4 + cells (25) . The same report documented that Runx1 binds to the regulatory region of the CD25 gene. A Runx1-overproducing T hybridoma cell line showed increased expression of CD25 induced by anti-CD3 Ab (47) . In contrast, Runx1 flox/flox Cd4-cre mice did not manifest autoimmune disease, and Treg cells express almost normal levels of CD25 and a slightly lower level of Foxp3 (48) . In addition, recent reports of Treg cell-specific Cbfbdeficient mice indicate that the Runx1-Cbfb complex has a crucial role in the suppressive function of Treg cells and in maintaining Foxp3 expression. However, CD25 expression is not changed in Treg cell-specific Cbfb-deficient mice (49, 50 (Fig. 7) . However, it was hard to assess the binding of Dec1 for Runx1 in Treg cells because of a very small amount of protein from those cells. It has also been recently reported that Dec2, another member of the Dec subfamily, plays a role in feed-forward regulatory circuits during Th2 differentiation (51) . This finding emphasizes the significance of transcriptional regulation by bHLH Dec subfamily members in inflammatory responses.
In summary, the data provide insight into how bHLH transcription factors modulate Treg development and how they act to regulate the inflammatory response particularly in mice beyond middle age. Cell proliferation and IL-2 production of CD4 or CD8 T cell upon TCR stimulation in Dec1 -/-mice. Purified CD4 + CD25 -CD62L high or CD8 + CD62L high T cells from were Dec1 +/+ or Dec1 -/-mice were labeled with CFSE, and stimulated with plate-bound anti-CD3 plus antiCD28Abs (5μg/ml). After 72h, cell were harvested, counted, and analyzed for CFSE dilution by flow cytometry. Concentration of IL-2 in the supernatants was determined by Cytometric Beads Assay (BD). Data represent the mean ±SD from three wells. 
